News

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults.

Analyzing donated brains from deceased people with Alzheimer’s disease who received amyloid-beta immunization, researchers found that when these treatments work, the brain’s immune cells help to restore a healthier brain environment.

A new clinical trial will allow researchers to study 3D-printed bioresorbable devices aimed at treating children with rare respiratory disease.

Johns Hopkins scientists have developed an mRNA “booster” as a potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins.

A new discovery about how tiny protein clusters form in cells could pave the way for treatments for Emery-Dreifuss muscular dystrophy, a rare genetic disorder.

Women with higher levels of essential minerals circulating in their blood during pregnancy, particularly copper and manganese, along with vitamin B12, had a lower risk of developing high blood pressure in middle age.

A study from the University of Utah Health suggests early antibiotic use may disrupt insulin-producing beta cells, increasing the risk of metabolic disorders like type 1 diabetes.

A research team has developed a non-opioid medication that shows promise in treating acute and chronic pain. The drug, known as VIP36, targets the body’s cannabinoid receptor type 1 (CB1).

A new study suggests that a small molecule drug that targets a specific serotonin receptor could become the first neurotherapeutic treatment for sarcopenia – offering hope for older adults struggling to stay strong.

A Monash-led study evaluated MDMA-assisted psychotherapy (MDMA-AP) for PTSD, finding symptom improvement but low-certainty evidence. The findings will inform Australia’s first clinical guidelines on MDMA-AP.